Results 21 to 30 of about 213,311 (303)
Visualizing nationwide variation in medicare Part D prescribing patterns
BMC Medical Informatics and Decision Making, 2018 Background To characterize the regional and national variation in prescribing patterns in the Medicare Part D program using dimensional reduction visualization methods.
Alexander Rosenberg +9 more
doaj +1 more source
Antimicrobial Stewardship & Healthcare Epidemiology, 2023 The 2007–2018 National Health Interview Survey data linked with Medicare claims were used to examine older adults’ characteristics and assess their associations with receiving an antibiotic prescription.
Christine Y. Kim +3 more
doaj +1 more source
The impact of Medicare part D on income-related inequality in pharmaceutical expenditure
International Journal for Equity in Health, 2019 Background Income-related inequality measures such as the concentration index are often used to describe the unequal distribution of health, health care access, or expenditure in a single measure.
Natalie Carvalho +4 more
doaj +1 more source
Medicare Part D and Portfolio Choice
American Economic Review, 2016 Economic theory suggests that medical spending risk affects the extent to which households are willing to accept financial risk, and consequently their investment portfolios. In this study, we focus on the elderly for whom medical spending represents a substantial risk.
Padmaja, Ayyagari, Daifeng, He
openaire +3 more sources
Lessons for Medicare Part D in the hemodialysis community
BMC Nephrology, 2006 Background Medicare beneficiaries without prescription drug coverage consistently fill fewer prescriptions than beneficiaries with some form of drug coverage due to cost.
Chertow Glenn M, Nayeem Anisa I
doaj +1 more source
Gabepentinoids and Benzodiazepines in Medicare Part D [PDF]
Journal of the American Society of Nephrology, 2018 I have read with interest the observational study regarding risks of adverse outcomes associated with gapapentin and pregabalin use.[1][1] The authors adeptly analyzed data in the US Renal Data System database, including Medicare Part D prescription drug events ( i.e.
openaire +2 more sources
Big Data fraud detection using multiple medicare data sources
Journal of Big Data, 2018 In the United States, advances in technology and medical sciences continue to improve the general well-being of the population. With this continued progress, programs such as Medicare are needed to help manage the high costs associated with quality ...
Matthew Herland +2 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2019 This study evaluated physician practices and perceived barriers for influenza, tetanus, diphtheria, pertussis (Tdap), and zoster vaccination of adults in the United States (US), with emphasis on patients with Medicare versus commercial insurance. A cross-
Michelle McNamara +6 more
doaj +1 more source
BMC Geriatrics, 2022 Background Proton pump inhibitors, benzodiazepines, and antipsychotics are considered potentially inappropriate medications in older adults according to the American Geriatric Society Beers Criteria, and deprescribing algorithms have been developed to ...
Jennifer M. Toth +3 more
doaj +1 more source
Plan Selection in Medicare Part D: Evidence from administrative Data [PDF]
, 2012 We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets, focusing on the ability of consumers to evaluate and optimize their choices of plans.
Heiss, Florian +3 more
core +4 more sources